Rheumnow
ACR 2023 Podcast - Day3D
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:16:22
- Mais informações
Informações:
Sinopse
Bimekizumab in Active AS_ 5 Year Study INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA Overlap of Inflammatory and Degenerative Features in Radiographic axSpA People with AxSpa Need More Sleep
